Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D06AFP
|
|||
Former ID |
DNC004978
|
|||
Drug Name |
N-Hydroxy-2-(naphthalen-2-ylsulfanyl)-acetamide
|
|||
Synonyms |
CHEMBL182879; 834918-57-9; N-Hydroxy-2-(naphthalen-2-ylsulfanyl)-acetamide; CTK3D2016; DTXSID40465831; BDBM50157325; AKOS030565680; Acetamide, N-hydroxy-2-(2-naphthalenylthio)-
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C12H11NO2S
|
|||
Canonical SMILES |
C1=CC=C2C=C(C=CC2=C1)SCC(=O)NO
|
|||
InChI |
1S/C12H11NO2S/c14-12(13-15)8-16-11-6-5-9-3-1-2-4-10(9)7-11/h1-7,15H,8H2,(H,13,14)
|
|||
InChIKey |
GNDJOJQVOFQQBM-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 834918-57-9
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Aminopeptidase N (ANPEP) | Target Info | Inhibitor | [1] |
BioCyc | Glutathione-mediated detoxification | |||
KEGG Pathway | Glutathione metabolism | |||
Metabolic pathways | ||||
Renin-angiotensin system | ||||
Hematopoietic cell lineage | ||||
Pathwhiz Pathway | Glutathione Metabolism | |||
Pathway Interaction Database | C-MYB transcription factor network | |||
Reactome | Metabolism of Angiotensinogen to Angiotensins | |||
WikiPathways | Metabolism of Angiotensinogen to Angiotensins | |||
Cardiac Progenitor Differentiation | ||||
miR-targeted genes in squamous cell - TarBase | ||||
miR-targeted genes in muscle cell - TarBase | ||||
miR-targeted genes in lymphocytes - TarBase | ||||
miR-targeted genes in leukocytes - TarBase | ||||
Glutathione metabolism |
References | Top | |||
---|---|---|---|---|
REF 1 | N-hydroxy-2-(naphthalene-2-ylsulfanyl)-acetamide, a novel hydroxamic acid-based inhibitor of aminopeptidase N and its anti-angiogenic activity. Bioorg Med Chem Lett. 2005 Jan 3;15(1):181-3. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.